Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

erythrocyte Membrane Protein Band 4.2 (EPB42) Peptide

EPB42 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN939552

Quick Overview for erythrocyte Membrane Protein Band 4.2 (EPB42) Peptide (ABIN939552)

Target

EPB42 (erythrocyte Membrane Protein Band 4.2 (EPB42))

Origin

Mammalian

Source

  • 1
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Peptide Type

    Synthetic

    Sequence

    ISTKGVGSDR CEDITQNYKY PEGSLQEKEV LERVEKEKME REKDNGIRPP

    Characteristics

    A synthetic peptide for use as a blocking control in assays to test for specificity of EPB42 antibody,
    Alternative Names: EPB42 control peptide, EPB42 antibody Blocking Peptide, Anti-EPB42 Blocking Peptide, Erythrocyte Membrane Protein Band 4.2 Blocking Peptide, EPB42, EPB-42, EPB 42, EPB-42 Blocking Peptide, EPB 42 Blocking Peptide

    Purification

    Prepared from rabbit serum by affinity purification using an AminoLink® Plus column matrix to which purified, recombinant bovine DDC was coupled.
  • Application Notes

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    -20 °C

    Storage Comment

    Store at -20 °C long term.
  • Target

    EPB42 (erythrocyte Membrane Protein Band 4.2 (EPB42))

    Background

    Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia.

    Molecular Weight

    80 kDa
You are here:
Chat with us!